A stylized illustration of REBOA being used in a trauma bay.

REBOA: A Lifeline in Severe Trauma?

Soraya Malik monogram
Soraya Malik in Health & Wellness October 2026 • 4 min read.

"Can resuscitative endovascular balloon occlusion of the aorta (REBOA) improve outcomes for hemodynamically unstable trauma patients?"


In the fast-paced world of emergency medicine, trauma care is constantly evolving. From damage control strategies to advanced imaging techniques, the goal is always to improve patient outcomes. One promising innovation is the resuscitative endovascular balloon occlusion of the aorta, or REBOA. This technique involves temporarily blocking the aorta with a balloon to redirect blood flow to vital organs.

But can REBOA truly make a difference in the most challenging cases? A recent retrospective study published in the World Journal of Emergency Surgery dives into this question, examining the effectiveness of REBOA in hemodynamically unstable patients with severe torso trauma. Let's explore the findings and what they mean for the future of trauma care.

Imagine a patient rushed into the emergency room with life-threatening injuries to the torso. Despite the best efforts of the medical team, the patient's blood pressure remains dangerously low. This is where REBOA comes in, offering a potential way to stabilize the patient and buy time for life-saving interventions.

AI Search Multiple angles on this topic

Nationwide Use Remains Limited

REBOA use for temporary hemorrhage control in severe non-compressible torso trauma remains controversial, with limited data on patient selection and outcomes. A nationwide study examined emergency-department REBOA trends from 2017 through 2022. Fewer than 200 programs reported using REBOA, and most emergency-department placements occurred at level 1 trauma centers.

REBOA: How Does It Work?

A stylized illustration of REBOA being used in a trauma bay.

REBOA works by temporarily blocking blood flow in the aorta, the body's largest artery. This redirects blood to the heart and brain, stabilizing the patient. The study focused on patients with severe torso trauma (Injury Severity Score > 16) who remained hypotensive despite initial resuscitation efforts. Researchers compared outcomes for patients who received REBOA versus those who did not.

The study meticulously tracked various factors, including patient characteristics, injury severity, time to intervention, and mortality rates. Statistical analysis helped determine whether REBOA made a significant difference in patient survival.

  • Patient Selection: Researchers analyzed data from 5,899 severe trauma patients, focusing on 107 with severe torso injuries and persistent hypotension.
  • REBOA Procedure: REBOA was performed by inserting a balloon catheter into the femoral artery and inflating it in the aorta to temporarily block blood flow.
  • Data Analysis: The study assessed the impact of REBOA on in-hospital mortality, time to hemostasis, and other clinical outcomes, using multivariable logistic regression to control for confounding variables.
AI Search Multiple angles on this topic

Expert Support for Selected Prehospital Use

An international expert panel concluded that REBOA can be used in civilian prehospital settings for temporary control of noncompressible truncal hemorrhage. The panel conditioned that use on properly trained personnel and established protocols. This recommendation frames prehospital REBOA as a controlled, protocol-dependent intervention rather than an unrestricted practice.

Trial Limitations Matter

A commentary examining the UK-REBOA trial argues that limitations in the study may have influenced its outcome. The trial reported results for 90 randomized patients, with 89 included in the primary outcome analysis after one patient in the standard-care group declined continued participation and data collection four days after enrollment. The reported participants had a median age of 41 years, and 69% were male, with a median Injury Severity Score of 41.

The results were compelling. The trauma management that involved REBOA was significantly associated with decreased mortality which resulted in adjusted odds ratio of survival, 7.430.

The Future of REBOA in Trauma Care

The use of REBOA without a delay in initiating resuscitative hemostasis may improve the outcomes in patients with multiple injuries associated with severe trauma. Optimal usage of REBOA may be beneficial in preventing cardiac arrest and preserving brain and coronary blood flow without harmful effects. Further studies to assess optimal usage criteria are needed.

AI Search Multiple angles on this topic

A Controversial Bridge to Definitive Care

A 2024 narrative review describes REBOA as a controversial hemorrhage-control intervention often presented as a bridge to definitive hemorrhage control. The review summarizes the technique's evolution and latest applications, with emphasis on clinical outcomes. A separate analysis used the American College of Surgeons Trauma Quality Improvement Program Participant Use File from 2017 to 2023 to study adults with severe isolated thoracic or abdominal trauma undergoing REBOA.

System Readiness Before Expansion

Integrating prehospital REBOA into emergency trauma care systems requires careful deliberation. The available source emphasizes weighing potential risks against potential benefits. It also identifies system-wide protocols and resource availability as central considerations for future implementation.

Early Emergency-Department Experience

A case series reported successful emergency-department placement of a REBOA catheter in five cases of out-of-hospital cardiac arrest at an academic medical center. Separately, a randomized clinical trial compared REBOA plus standard care with standard care alone in emergency-department trauma patients with exsanguinating hemorrhage. These reports illustrate both early real-world application and formal evaluation of REBOA in critically injured patients.

REBOA mortality results depend on the comparison

  • 0.38Compared with resuscitative thoracotomy (RT), REBOA was associated with lower mortality (aOR 0.38).[1]
  • 1.40Compared with no REBOA, the comparison found no difference in mortality (aOR 1.40).[1]Caveat: No difference was observed
  • 0.86For unstable trauma patients with subdiaphragmatic bleeding, the comparison of REBOA with no REBOA found no significant mortality difference (OR 0.86).[2]Caveat: No significant difference
  • 2.15In the pelvic-fracture subgroup, mortality was higher with REBOA than with no REBOA (OR 2.15).[2]

How trial reports and later evidence frame REBOA

A commentary on a UK trial described early stopping before the intended enrollment was reached and cautioned that randomization may not have produced comparable groups. It also reported that balloon occlusion was performed in only some REBOA-group patients and that arterial access failed in some cases.[3]

The commentary describes proximal aortic occlusion as a way to limit blood flow to the injury site, while also noting that REBOA may raise pressure above the occlusion and that this could be harmful in the presence of cerebral hemorrhage. These points describe a proposed mechanism and a potential harm, not proof of a net benefit.[3]

One source estimates that hemorrhage accounts for 30–40% of traumatic deaths, establishing the broader stakes of hemorrhage control without resolving REBOA’s comparative effect.[4]

What evidence could clarify REBOA's role

  • Would comparisons with more complete balloon use and successful arterial access produce a clearer estimate of REBOA’s contribution?[3]
  • Do partial and complete occlusion differ in the clinical outcomes being assessed, including distal ischemia, safe occlusion time, hemodynamics, bleeding, and blood-product use?[5]

Sources

  1. Resuscitative endovascular balloon occlusion of the aorta (REBOA) in patients with major trauma and uncontrolled haemorrhagic shock: a systematic review with meta-analysis (pmc.ncbi.nlm.nih.gov)
  2. Resuscitative Endovascular Balloon Occlusion of the Aorta in surgical and trauma patients: a systematic review, meta-analysis and practice management guideline from the Eastern Association for the Sur (pmc.ncbi.nlm.nih.gov)
  3. The end of balloons? Our take on the UK-REBOA trial (link.springer.com)
  4. Use of resuscitative endovascular balloon occlusion of the aorta (REBOA) for trauma and its performance in Japan over the past 18 years: a nationwide descriptive study (pmc.ncbi.nlm.nih.gov)
  5. A PROMPT Update on Partial REBOA: Initial Clinical Data and Overview of the DoD-Funded Partial REBOA Outcomes Multicenter ProspecTive (PROMPT) Study. (pubmed.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What exactly is REBOA?

Resuscitative endovascular balloon occlusion of the aorta, or REBOA, is a procedure where a balloon catheter is inserted into the femoral artery and inflated in the aorta. This temporarily blocks blood flow in the aorta, redirecting blood to the heart and brain. The goal is to stabilize the patient by preserving brain and coronary blood flow.

2

Why is REBOA considered a significant advancement in trauma care?

REBOA is significant because it offers a potential way to stabilize hemodynamically unstable trauma patients, particularly those with severe torso injuries and persistent hypotension, buying time for life-saving interventions. It has been shown that REBOA may improve survival rates in patients with multiple injuries associated with severe trauma.

3

How was the effectiveness of REBOA evaluated in the study?

The study analyzed data from 5,899 severe trauma patients, focusing on 107 with severe torso injuries and persistent hypotension. Researchers compared outcomes for patients who received REBOA versus those who did not, tracking factors like patient characteristics, injury severity, time to intervention, and mortality rates.

4

Are there any potential risks or downsides to using REBOA?

The use of REBOA may have potential complications, that's why the 'optimal usage criteria' needs to be assessed. To maximize its benefits and minimize risks, it is essential to identify the right patient population and timing for intervention. Further research is needed to determine the best strategies for implementing REBOA in various trauma scenarios.

5

What are the broader implications of the study's findings on the use of REBOA in trauma care?

The study's findings suggest that REBOA may improve outcomes in patients with severe torso trauma and persistent hypotension. However, it's important to note that the study focused on a specific patient population and setting. While REBOA shows promise, it is crucial to consider patient selection, timing, and potential complications.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.